Johnson & Johnson JNJ is scheduled to announce its second quarter financial results on Tuesday before the market opens. According to Estimize, the company is expected to deliver the strongest quarter in its history, in terms of earnings.
Both the Street and the crowd are modeling consensus earnings of $1.72 per share for the current quarter. Revenue is expected to come in somewhere in the $17.63 billion to $17.66 billion range.
These figures compare to last quarter’s earnings of $1.56 per share on sales of $17.374 billion, and to earnings of $1.66 per share on revenue of $19.495 billion reported in the second quarter of 2014.
Moreover, as it can be seen in the chart, Johnson & Johnson has a history of surpassing earnings estimates.
Related Link: Strong Dollar? Not So Good For Johnson & Johnson Earnings
The Cons Of A Strong Dollar
Most companies with strong global footprints are feeling the effects of a strong U.S. Dollar. However, one debate remains regarding the intensity of the impact.
In a note recently published on Zacks, analysts say they see pharma product sales and newly launched products driving growth in Johnson & Johnson.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
